DiNuzzo Private Wealth’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
DPCM
DiNuzzo Private Wealth's PCRX Position: Q3 2024 in Review
DiNuzzo Private Wealth sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 6 shares — an estimated $172 sold.
DiNuzzo Private Wealth first reported a position in PCRX in Q4 2023 and held it in 3 quarters. The position peaked at $172 in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.
- DiNuzzo Private Wealth reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
- DiNuzzo Private Wealth sold 6 Pacira BioSciences shares in Q3 2024, an estimated $172.
- DiNuzzo Private Wealth first reported a position in Pacira BioSciences in Q4 2023 and held it in 3 quarters.
- DiNuzzo Private Wealth's Pacira BioSciences position peaked at $172 in Q2 2024.
- 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.
Based on DiNuzzo Private Wealth's 13F filing for Q3 2024, filed 17 Oct 2024.